Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 82009-113
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 82009-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Container50mg (Container50mg)
This is a description for a medication called Metoprolol Succinate. Each film-coated tablet contains 47.5 mg of metoprolol succinate, which is equivalent to 50 mg of metoprolol tartrate. The usual dosage is detailed in the package insert. It is important to keep this medication out of the reach of children. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The medication is in the form of extended-release tablets. It is manufactured by Dr. Reddy's Laboratories Limited based in Bachupally, India. The medication is intended for use under prescription only. It is manufactured for Quallent Pharmaceuticals Health LLC. The product contains 500 tablets. Further details such as expiration date, lot number, and a 2D code are also provided.*
Figure (Figure)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.